The US Immunohistochemistry Market is being shaped by continued demand for tissue-based diagnostics, biomarker testing, and advanced pathology workflows. Hospitals and diagnostic laboratories are increasingly incorporating automated staining systems and digital pathology technologies into routine operations. Growing use of immunohistochemistry in oncology and other disease areas is supporting...
The CD68 Market is benefiting from the increasing adoption of multiplex immunohistochemistry. Combining CD68 with other cellular markers enables researchers to characterize immune-cell populations and examine their spatial relationships within tissue samples.
The CD68 Market was valued at US$ 804.62 million in 2025 and is expected to reach US$ 1,563.69 million by 2034, registering a CAGR of...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek